Vertex Pharmaceuticals Inc / Ma

Geneos Wealth Management Inc. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

102

Value ($000)

Weight

0.0%

2016 Q1 - 2025 Q4 (40 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	46	0.0%	102	12/31/2025
2025 Q3	10/22/2025	46	0.0%	117	9/30/2025
2025 Q2	8/18/2025	842	0.0%	1,892	6/30/2025
2025 Q1	5/8/2025	1,496	0.0%	3,086	3/31/2025
2024 Q4	1/21/2025	585	0.0%	1,453	12/31/2024
2024 Q3	11/14/2024	789	0.0%	1,697	9/30/2024
2024 Q2	7/23/2024	35	0.0%	74	6/30/2024
2024 Q1	5/3/2024	29	0.0%	69	3/31/2024
2023 Q4	1/26/2024	34	0.0%	84	12/31/2023
2023 Q3	10/11/2023	66	0.0%	191	9/30/2023
2023 Q2	8/8/2023	48	0.0%	137	6/30/2023
2023 Q1	4/25/2023	2	0.0%	7	3/31/2023
2022 Q4	1/31/2023	37	0.0%	127	12/31/2022
2022 Q3	11/14/2022	36	0.0%	127	9/30/2022
2022 Q2	7/22/2022	127	0.0%	445	6/30/2022
2022 Q1	5/16/2022	116	0.0%	445	3/31/2022
2021 Q4	2/9/2022	71	0.0%	325	12/31/2021
2021 Q3	11/9/2021	40	0.0%	225	9/30/2021
2021 Q2	7/8/2021	44	0.0%	224	6/30/2021
2021 Q1	6/17/2021	568	0.0%	2,604	3/31/2021
2020 Q4	5/19/2021	605	0.0%	2,958	12/31/2020
2020 Q3	9/7/2021	163	0.0%	608	9/30/2020
2020 Q2	9/7/2021	259	0.0%	908	6/30/2020
2020 Q1	9/7/2021	138	0.0%	638	3/31/2020
2019 Q4	9/7/2021	118	0.0%	538	12/31/2019
2019 Q3	9/7/2021	89	0.0%	538	9/30/2019
2019 Q2	9/7/2021	96	0.0%	524	6/30/2019
2019 Q1	9/7/2021	105	0.0%	574	3/31/2019
2018 Q4	9/7/2021	96	0.0%	598	12/31/2018
2018 Q3	9/7/2021	115	0.0%	598	9/30/2018
2018 Q2	9/7/2021	96	0.0%	569	6/30/2018
2018 Q1	9/7/2021	104	0.0%	639	3/31/2018
2017 Q4	9/7/2021	95	0.0%	639	12/31/2017
2017 Q3	9/7/2021	107	0.0%	706	9/30/2017
2017 Q2	9/7/2021	32	0.0%	253	6/30/2017
2017 Q1	9/7/2021	27	0.0%	253	3/31/2017
2016 Q4	9/7/2021	20	0.0%	275	12/31/2016
2016 Q3	9/7/2021	23	0.0%	275	9/30/2016
2016 Q2	9/7/2021	22	0.0%	253	6/30/2016
2016 Q1	9/7/2021	20	0.0%	253	3/31/2016